glp-1 medications market 2025 Analogues Size to Hit USD 1,062.90 Billion by 2035 GLP-1 Market Trends and Global

If these projections hold, orforglipron could become the first GLP-1 therapy that is realistically accessible to the tens of millions of Americans who qualify for treatment but cannot currently get it

PMCID: PMC6219651

Update on FDAs ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity: Preliminary evaluation does not suggest a causal link [Drug Safety Communication]

Patients who involve a family memberasking a spouse, roommate, or friend to send a reminder textreport 92% adherence rates over 12 weeks

Thinner needles higher gauge numbers -are generally less painful

Where needed, anaesthesia is provided to ensure patient comfort throughout the session